Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesothelioma.
Saved in:
| Title: | Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesothelioma. |
|---|---|
| Authors: | Fang, XiaoChang1,2,3 (AUTHOR), Shu, Lin1,2,3 (AUTHOR), Chen, TianLiang1,2,3 (AUTHOR), Zhao, XiaoLe1,2,3 (AUTHOR), Yang, LiuCui2,4 (AUTHOR), Dou, Tingting1,2,3 (AUTHOR), Yang, Lijie1,2,3 (AUTHOR), Li, Xuanfei1,2,3 (AUTHOR) lxf8591@163.com, Feng, Maohui1,2,3 (AUTHOR) fengmh5690@163.com |
| Source: | Molecular Cancer. 1/10/2024, Vol. 23 Issue 1, p1-21. 21p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14764598 |
|---|---|
| DOI: | 10.1186/s12943-023-01901-z |
